Immunological and clinical features of T-cell LGL leukemia

EHA Library, Estella Matutes, 3446

Predictors of clinical severiy in sickle cell disease

EHA Library, Martin Steinberg, 3430

Pediatric AML

EHA Library, Gertjan Kaspers, 3426

NK cell disorders

EHA Library, Gianpietro Semenzato, 3445

Red cell membrane disorders

EHA Library, Mohandas Narla, 3429

Pedriatic MDS

EHA Library, Charlotte Niemeyer, 3425

Pathogenesis of multiple myeloma

EHA Library, Gareth Morgan, 3413

Lymphocyte-predominant Hodgkin's lymphoma in children and young adults

EHA Library, Judith Landman-Parker, 3409

Molecular basis of aggressive lymphoma

EHA Library, Andreas Rosenwald, 3401

Stem cell persistence in CML

EHA Library, Michael W Deininger, 3393

Von Willebrand factor: its role in haemostasis and thrombosis

EHA Library, Karen Vanhoorelbeke, 3385

AML biology & leukemic stem cells

EHA Library, Brian Huntly, 3381

EHA14 José Carreras Young Investigator Award

EHA Library, Catherine Lacombe, 3451

EHA14 Opening Ceremony : Congress President's Speech

EHA Library, Rüdiger Hehlmann, 3450

EHA14 Opening Ceremony: President's Speech

EHA Library, Wim Fibbe, 3449

Stem cells in pre leukemia and leukemia

EHA Library, Tariq Enver, 2106

Microparticles, thrombosis and cancer

EHA Library, Bruce Furie, 2105

Chronic lymphoid leukemia - current concepts of molecular pathogenesis and therapy

EHA Library, Michael Hallek, 2104

Signature-based approaches to leukemia discovery

EHA Library, Kimberly Stegmaier, 2196

Molecular pathogenesis of B cell lymphomas

EHA Library, Riccardo Dalla-Favera, 2103

IFN-A Promotes Proliferation of Dormant HSCs in vivo, Making Them Susceptible to Elimination by Chemotherapy

EHA Library, Marieke Essers, 2209

Unique Activating Mutations of JAK2 in The Acute Lymphoblastic Leukemias of Down Syndrome -Biological And Therapeutic Applications

EHA Library, Shai Izraeli, 2208

Superior Efficacy With Bortezomib Plus Melphalan–Prednisone (VMP) Versus Melphalan–Prednisone (MP) Alone In Previously Untreated Multiple Myeloma (MM): Results of The Phase III MMY-3002 Vista Study

EHA Library, Jesús San Miguel, 2207

Biallelic Mutations in The Telomerase Component NHP2 Cause The Premature Ageing Syndrome Dyskeratosis Congenita

EHA Library, Tom Vulliamy, 2206

Mutation in TMPRSS6, a Suppressor of Hepcidin Gene Expression, in Familial Iron Deficiency Anemia

EHA Library, Renzo Galanello, 2205

Relationship between academia and pharma

EHA Library, Mike Greaves, 2198

EHA13 Presentation EHA-José Carreras Young Investigator Fellowship & EHA Fellowships

EHA Library, Christina Mecucci, 2343

Chronic myeloid leukemia - yesterday, today and tomorrow

EHA Library, John Goldman, 2197

EHA13 Opening Ceremony : Congress President's Speech

EHA Library, Niels Borregaard, 2350

EHA13 Opening Ceremony: President's Speech

EHA Library, Wim Fibbe, 2342

Allogeneic transplants and immune intervention in multiple myeloma

EHA Library, Henk Lokhorst, 2124

Clinical implications of genetic abnormalities in myeloma

EHA Library, Johannes Drach, 2146

Targeted therapy of diffuse large cell lymphoma

EHA Library, Anas Younes, 2160

Treating diffuse large B-cell lymphoma: optimizing the use of anti-CD20 antibodies

EHA Library, Gilles Salles, 2159

Treatment of relapsed multiple myeloma

EHA Library, Jesús San Miguel, 2148

Frontline treatment in multiple myeloma patients ineligible for stem cell transplantation

EHA Library, Thierry Facon, 2147

Hodgkin lymphoma in the elderly: current status and future directions

EHA Library, Stephen Proctor, 2156

Management of immune thrombocytopenic purpura in adults

EHA Library, James Bussel, 2142

Immunopathogenesis, immunomodulation and management of immune thrombocytopenic purpura in children

EHA Library, Paul Imbach, 2141

Congenital platelet disorders

EHA Library, Marco Cattaneo, 2140

Blastic transformation in myeloproliferative disorders: science and therapy

EHA Library, Ruben Mesa, 2139

Management of primary myelofibrosis

EHA Library, Giovanni Barosi, 2138

Stratified management of essential thrombocythemia and polycythemia vera

EHA Library, Alessandro M. Vannucchi, 2137

Molecular pathogenesis of acute lymphoblastic leukemia: an IG/TCR-centric view

EHA Library, Elizabeth Macintyre, 2116

Management of adolescents with acute lymphoblastic leukemia: implications for adult therapy

EHA Library, David Webb, 2118

Pathogenesis and therapeutic targets in myelodysplastic syndromes

EHA Library, Simone Boehrer, 2119

Defining the role of epigenetic therapy in myelodysplastic syndromes

EHA Library, Steven Gore, 2120

Immunomodulatory drugs (IMiDs) in myelodysplastic syndromes: long-term outcome

EHA Library, Alan List, 2121

Cellular therapy to rebuild immunity after stem cell transplantation

EHA Library, Helen Heslop, 2122

Immunological and clinical aspects of double cord blood transplants

EHA Library, Claudio Brunstein, 2123

New advances in iron chelation

EHA Library, Renzo Galanello, 2136

Biology of Hodgkin lymphoma

EHA Library, Daniel Re, 2155

Molecular control of hemoglobin F production and the implications for therapy

EHA Library, Swee Lay Thein, 2135

Evaluation of the severity of bleeding disorders

EHA Library, Francesco Rodeghiero, 2129

Treatment of bleeding disorders with pro-hemostatic drugs

EHA Library, Jorgen Ingerslev, 2130

Past and present screening assays to evaluate hemostasis

EHA Library, Waander van Heerde, 2128

Using novel targeted drug therapy for front-line management of pediatric acute leukemia

EHA Library, Gregory Reaman, 2115

Characteristics and management of patients with very high risk childhood acute lymphoblastic leukemia

EHA Library, Martin Schrappe, 2114

Genes and proteins mediating drug resistance in acute lymphoblastic leukemia

EHA Library, Rob Pieters, 2113

New agents for the treatment of acute myeloid leukemia

EHA Library, Sergio Amadori, 2112

Genetic profiling and its impact on treatment of acute myeloid leukemia

EHA Library, Hartmut Döhner, 2111

Gene expression profiling to distinguish acute myeloid leukemia subtypes: discovery of a novel subtype with unique molecular and biological features

EHA Library, Ruud Delwel, 2110

Autoimmune neutropenia

EHA Library, Stephan Ehl, 2144

Chronic idiopathic neutropenia: clinical and pathophysiologic aspects

EHA Library, Helen Papadaki, 2145

The role of new agents in the management of chronic myeloid leukemia

EHA Library, Michael W Deininger, 2109

Imatinib resistance: the role of BCR-ABL dependent and BCR-ABL independent mechanisms in the loss of response to tyrosine kinase inhibitors

EHA Library, Giovanni Martinelli, 2108

Molecular mechanisms of transformation and leukemogenesis by BCR-ABL

EHA Library, Rick van Etten, 2107

Clues on the origin and behaviour of chronic lymphocytic leukemia cells

EHA Library, Paolo Ghia, 2152

Prognostic markers in chronic lymphocytic leukemia

EHA Library, Jesper Jurlander, 2153

Hemostasis and cancer

EHA Library, Frederick Rickles, 2125

Genomic instability in leukemia

EHA Library, Pier Guiseppe Pelicci, 1368

Gene therapy for red cell disorder

EHA Library, Michel Sadelain, 1367

Optimizing anti-thrombotic treatment: the role of new and established agents

EHA Library, Harry Büller, 1366

Identification of the chromatin-remodeling protein SATB1 as a development-dependent long-range transcriptional regulator of the PU.1 gene

EHA Library, Ulrich Steidl, 1361

The JAK2 V617F mutation is present in a minority of human hematopoietic stem cells from patients with myeloproliferative disorders and does not modify their self-renewal properties

EHA Library, Chloé James, 1359

Primary allogeneic stem cell transplantation versus best available drug treatment in chronic myeloid leukemia

EHA Library, Rüdiger Hehlmann, 1357

Stem cell banking

EHA Library, Wim Fibbe, 1364

Stem cell banking

EHA Library, David Scadden, 1363

Thrombophilia: from single gene disorder to complex disease

EHA Library, Rogier Bertina, 1365

Genome-wide approaches to identify new subtypes of acute myeloid leukemia (AML)

EHA Library, Peter VALK, 1354

Immunotherapy of leukemia with TCR gene modified T cells

EHA Library, Hans Stauss, 1349

The molecular and cellular basis for immunotherapeutic intervention in malignant disease: dynamic imaging of the immune system

EHA Library, Carina Lotz, 1348

New developments in curative approaches in myelodysplasia

EHA Library, Theo De Witte, 1341

Epigenetic therapy in MDS

EHA Library, Pierre Fenaux, 1340

Molecular pathogenesis of myelodysplastic syndromes

EHA Library, Charlotte Niemeyer, 1339

Detection of minimal residual disease in adult patients with acute lymphoblastic leukemia: methodological advances and clinical significance

EHA Library, Monika Brüggemann, 1335

Genetics of T-cell acute lymphoblastic leukemia

EHA Library, Christine Harrison, 1333

Hydroxyurea: benefits and risks in patients affected with sickle cell anemia

EHA Library, Mariane de Montalembert, 1332

The contribution of asthma to sickle cell disease related morbidity and mortality

EHA Library, Michael DeBaun, 1331

Hemolysis-associated pulmonary hypertension in sickle cell disease and thalassemia

EHA Library, Gregory Kato, 1330

Novel treatment approaches in multiple myeloma

EHA Library, Antonio Palumbo, 1326

Multiple myeloma: diagnosis, staging and criteria of response

EHA Library, Joan Bladé, 1325

Advances in myeloma biology: basis for new therapy

EHA Library, Nikhil Munshi, 1324

Novel drugs for the treatment of T-cell lymphoma

EHA Library, Owen O'Connor, 1323

Current treatment of T-cell lymphomas: are we making any progress?

EHA Library, Alain Delmer, 1322

Pathology and genetics of T-cell lymphomas

EHA Library, Andreas Chott, 1321

Venous thromboembolism in medical patients: stratification and prevention

EHA Library, Paolo Prandoni, 1317

Do arterial and venous thrombosis share common risk factors?

EHA Library, Gordon Lowe, 1316

VKORC1: pharmacogenetics and oral anticoagulation

EHA Library, Johannes Oldenburg, 1315

Mechanisms of iron regulation and of iron deficiency

EHA Library, Chaim Hershko, 1308